biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Midatech at $1.0475

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Dec 31, 2022 3:00pm

85 Views

Post# 35198588

RE:RE:RE:RE:RE:RE:RE:RE:Midatech at $1.0475

"By obsessively fearing dilution so much BTI has been slow-walked into catastrophic dilution."

Even POF can admit this is catastrophic.

--------

As I've said, a 1-in-100 year flood has wiped out Biotech City. This has been the worst biotech market in history. With much of the industry trading near or below the cash on the balance sheet catastrophic dilution shouldn't be surprising. Catastrophic dilution is normal as much science is being given negative value. Many will suffer worse than BTI which was also leveraged. Rathjen has tried to act decisively to provide upside and provide enough cash to get to key catalysts amidst the general carnage in Biotech City.

Image result for catastrophic flooding